'Cv risk factors' diaporamas de présentation

Approach to Management of Hypertension

Approach to Management of Hypertension. Prof. Abdulkareem Al-Suwaida, MD, FRCPC, MSc 442- 2017. Objectives of The Lecture. Discuss the Prevalence of HTN in KSA Understand how to diagnose h ypertension Evaluation and Risk Assessment of patients How to screen for Secondary Causes of HTN

864 views • 54 slides

677 views • 48 slides

625 views • 48 slides

Hypertension and The Older Patient

Hypertension and The Older Patient. Debra L. Bynum, MD Assistant Professor Division of Geriatric Medicine University of North Carolina. Outline. Defining Systolic Hypertension Risks of SH in older persons Preventing stroke, CHF, CV events, dementia Review of Major Trials

475 views • 30 slides

Hypertension and The Older Patient

Hypertension and The Older Patient. Debra L. Bynum, MD Assistant Professor Division of Geriatric Medicine University of North Carolina. Outline. Defining Systolic Hypertension Risks of SH in older persons Preventing stroke, CHF, CV events, dementia Review of Major Trials

309 views • 30 slides

Adverse Health and Social Consequences Associated With Obesity

Adverse Health and Social Consequences Associated With Obesity. Goals and Targets for CV Risk Factors. CVOTs With GLP-1 RAs. CVOTs With SGLT2 Inhibitors. Mechanisms of Action of Liraglutide for Weight Loss. Renal Outcomes With Glucose-Lowering Agents. Abbreviations. Abbreviations (cont).

235 views • 8 slides

KYOTO

KYOTO. BP at follow-up: 133/76 mm Hg in both groups Composite CV events: 5.5% with valsartan vs. 10.2% with usual therapy Stroke/TIA: 1.5% vs. 3% Angina: 1.5% vs. 2.9% (p = 0.01) New-onset DM: 5.2% vs. 7.7% (p = 0.028).

185 views • 1 slides